Interventions targeting executive functions in children and young people exposed to complex trauma: A systematic review.

Neuropsychol RehabilDec 26, 2025 (epub)
Clinical ResearchPsychiatryPediatrics

Sophie Branch, Melanie Porter

✦ AI-curated · Sources linked

In 30 seconds

This PRISMA-guided systematic review examined interventions targeting executive function (EF) in children and young people exposed to complex trauma, including abuse, neglect, and violence. The review identified six studies: three of computerized cognitive training, two of individual education plans, and one of trauma-focused cognitive behavioural therapy. Findings indicated significant EF improvements with computerized cognitive training and trauma-focused cognitive behavioural therapy; both approaches were judged to warrant further investigation. The review concluded that the evidence remains insufficient to establish intervention efficacy or inform robust clinical practice guidelines.

Key findings

  • The review identified six studies: three evaluated computerized cognitive training, two individual education plans, and one trauma-focused cognitive behavioural therapy.
  • Computerized cognitive training and trauma-focused cognitive behavioural therapy were associated with significant improvements in executive function and warrant further study.

Why it matters

Executive-function difficulties in young people exposed to complex trauma are linked to poorer academic, social, and relational outcomes and reduced wellbeing. This review identifies two intervention approaches with promising findings, while underscoring that the evidence base is not yet strong enough to establish which approaches reliably improve executive function in this population.

What to keep in mind

The review identified inadequate control groups, limited consensus on classifying executive-function domains, and insufficient delineation of trauma type, onset, and duration.

Source

Published in Neuropsychol Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.